Empatica SRL is recalling approximately 1,360 units of its Embrace2 seizure monitoring watch because the battery life may last less than the promised 48 hours. This defect requires users to charge the device more frequently than expected, which could lead to the device powering off unexpectedly and failing to monitor for seizures. The recall affects several colors including Flamingo Pink, Sky Blue, Seoul Grey, Boston Blue, and Milan Black distributed worldwide.
If the battery drains faster than 48 hours, the device may shut down without the user's knowledge, resulting in a failure to monitor and alert caregivers during a seizure event. This poses a risk of serious injury or delayed medical intervention for individuals with epilepsy.
Manufacturer instructions via email notification.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.